Amylyx Pharmaceuticals

Amylyx Pharmaceuticals

Yahoo Finance • 8 days ago

Amylyx Pharmaceuticals to Present at the Stifel 2026 Virtual Cardiometabolic Forum

CAMBRIDGE, Mass., September 23, 2026--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced that management will present at the Stifel 2026 Virtual Cardiometabolic Forum. The fireside chat... Full story

Yahoo Finance • 14 days ago

10 mid-cap healthcare stocks with the strongest momentum grades

Mid-cap U.S. healthcare stocks have exhibited strong momentum traits year to date, with several names earning A-range momentum grades that indicate stronger price performance trends relative to sector peers. Seeking Alpha's Quant Momentum... Full story

Yahoo Finance • 21 days ago

Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?

The Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) provides broad healthcare exposure at a fraction of the cost of the State Street SPDR S&P Pharmaceuticals ETF (NYSEMKT:XPH), which targets a specific industry niche. Investors seeking... Full story

Yahoo Finance • last month

Should Eli Lilly Investors Be Worried About a Threat From Amylyx?

Eli Lilly (NYSE: LLY) was the second company to market a GLP-1 drug. That's important to keep in mind as you look at the competitive landscape for this new class of weight-loss drugs. In some ways, investors do need to worry that companies... Full story

Yahoo Finance • last month

Oracle Stock And 2 High Growth Picks Backed By Rising Credit Demand

Eurozone private sector credit growth is gaining pace, which points to households and businesses feeling more confident about borrowing for spending and investment. That kind of backdrop can support companies with healthy balance sheets an... Full story

Yahoo Finance • last month

Biggest stock movers Tuesday: BIDU, FLXS, FN, and more

[Emerging Financial Data - Stock Market, Prosperity, Bull Market - Blue Version] DKosig Stock futures edged lower on Tuesday as investors weighed a fresh surge in crude oil prices driven by stalled diplomatic talks and lingering concerns... Full story

Yahoo Finance • 2 months ago

Biotech Stocks At 52-Week Highs - HALO +20% On Q2 Results, FENC, AVLN, AMLX, CHE

(RTTNews) - The following biotech stocks reached 52-week highs on August 7, 2026, driven by key catalysts such as positive quarterly reports or upcoming clinical results. Halozyme Therapeutics Inc. (HALO) Halozyme is a biopharmaceutical... Full story

Yahoo Finance • 2 months ago

Catalyst Watch: Inflation reads, AMAT earnings, Google Pixel event, and MLB on Netflix

[Lower Manhattan Cityscape] Art Wager/E+ via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week.... Full story

Yahoo Finance • 2 months ago

Catalyst Watch: Jobs report, SpaceX's first report, AMD, and SK Hynix ratings

[Wall Street New York stock exchange stock market] alexsl Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week.... Full story

Yahoo Finance • 3 months ago

Citi's picks and pans for H2 '26: REITs, tech, consumer, health

[Citibank headquarters in Canary Wharf, London, UK] VV Shots Citi released its roadmap for the second half of 2026, including a macro-to-micro view of equity sectors. "Our recently revised S&P 500 (SPY [https://seekingalpha.com/symbol/SP... Full story

Yahoo Finance • 3 months ago

Is Amylyx Pharmaceuticals, Inc. (AMLX) Stock Ready for a Breakout Ahead of Key LUCIDITY Trial Data?

We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is one of the best low-priced pharma stocks on this list. TheFly reported on June 25 that Guggenheim raised i... Full story

Yahoo Finance • 3 months ago

Is Teva Pharmaceutical Industries Limited (TEVA) Stock Undervalued After Recent Pullback and Vitiligo Program Update?

We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best low-priced pharma stocks on this list. TheFly reported on June 18 that Jefferies a... Full story

Yahoo Finance • 4 months ago

What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors

Key Points Saturn V sold 1,504,880 shares of Ocular Therapeutix in the first quarter; the estimated transaction value was $14.34 million. Meanwhile, the quarter-end position value declined by $18.27 million, reflecting both share sales an... Full story

Yahoo Finance • 5 months ago

Amylyx Pharmaceuticals Q1 Earnings Call Highlights

Amylyx Pharmaceuticals logo Key Points Avexitide Phase 3 LUCIDITY completed dosing and the company says it’s on track for a near-term top-line readout, with management and the CFO pointing to potential readout timing around Q3 2026. Expa... Full story

Yahoo Finance • 6 months ago

Amylyx Pharmaceuticals (AMLX) Winds Up Avexitide Phase 3 Lucidity Trial Enrollment

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the 7 best small-cap drug manufacturing stocks to buy according to hedge funds. On March 24, Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) stated that the final subject in the Phase 3 Lucidi... Full story

Yahoo Finance • 7 months ago

Pre-Market Earnings Report for March 3, 2026 : AZO, TGT, SE, VIK, ONON, BBY, THO, SRRK, SRAD, KTB, MRX, AMLX

The following companies are expected to report earnings prior to market open on 03/03/2026. Visit our Earnings Calendar for a full list of expected earnings releases. AutoZone, Inc. (AZO)is reporting for the quarter ending February 28,... Full story

Yahoo Finance • 10 months ago

This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy?

Key Points Austin-based Saturn V Capital Management acquired 886,332 shares of Pharvaris in the third quarter. Saturn V now holds 886,332 PHVS shares valued at $22.1 million. PHVS is a new addition, accounting for 4.9% of 13F AUM, which p... Full story

Yahoo Finance • 10 months ago

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow?

Key Points Austin-based Saturn V Capital Management added 1.3 million shares of Amylyx Pharmaceuticals in the third quarter. The overall position increased in value by $41.2 million from quarter to quarter. Saturn V now holds 4.6 million... Full story

Yahoo Finance • 10 months ago

Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets

Key Points Austin-based Saturn V Capital Management added 1.2 million shares of Dyne Therapeutics during the third quarter. The overall position increased in value by $20 million from quarter to quarter. Saturn V now holds nearly 2.7 mill... Full story

Yahoo Finance • 11 months ago

December 2026 Options Now Available For Amylyx Pharmaceuticals (AMLX)

Investors in Amylyx Pharmaceuticals Inc (Symbol: AMLX) saw new options become available today, for the December 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so... Full story